Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
04/15 16:29 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
03/13 17:40 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
02/15 16:28 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Levy Adam Scott
02/15 16:28 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Congleton Jon
02/15 16:28 (美東)
Mineralys Therapeutics | SC 13G:超過5%持股股東披露文件-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%)等
02/15 16:23 (美東)
Mineralys Therapeutics | 4:持股變動聲明-董事 AKKARAJU SRINIVAS
02/14 21:08 (美東)
Mineralys Therapeutics | 4:持股變動聲明-股東 Samsara BioCapital GP, LLC
02/14 21:08 (美東)
Mineralys Therapeutics | 4:持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.
02/14 19:53 (美東)
Mineralys Therapeutics | SC 13G:超過5%持股股東披露文件-Adams Street Partners, LLC(5.60%),Adams Street Growth Equity Fund VII LP(2.17%)等
02/14 06:07 (美東)
Mineralys Therapeutics | SC 13G:超過5%持股股東披露文件-Catalys Pacific Fund, LP(22.4%),Catalys Pacific Fund GP, LP(22.4%)等
02/13 16:21 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
02/13 16:12 (美東)
Mineralys Therapeutics | SC 13G:超過5%持股股東披露文件-HBM Healthcare Investments (Cayman) Ltd.(5.5%)
02/13 16:11 (美東)
Mineralys Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
02/12 16:53 (美東)
Mineralys Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Samsara BioCapital, L.P.(10.3%),Samsara BioCapital GP, LLC(10.3%)等
02/12 16:51 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
01/12 00:00 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
2023/12/12 17:08 (美東)
Mineralys Therapeutics | 4:持股變動聲明-首席執行官 Congleton Jon
2023/11/27 16:01 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
2023/11/14 18:18 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
2023/11/07 17:15 (美東)
暫無數據
暫無數據